 |
|
UT School of Public Health researchers discover significant efficacy of travelers' diarrhea vaccine
June 12, 2008Researchers at The University of Texas School of Public Health have found that patients given a travelers' diarrhea vaccine were significantly less likely to suffer from clinically significant diarrhea than those who received placebo, according to a study published in this week's edition of the Lancet. The patch-based vaccine is part of the Phase 2 study in conjunction with the Iomai Corporation.
The study, which followed 170 healthy travelers ages 18-64 to Mexico and Guatemala, found that of the 59 individuals who received the novel vaccine, only three suffered from moderate or severe diarrhea, while roughly two dozen of the 111 who received a placebo suffered from moderate or severe diarrhea. Only one of the 59 volunteers in the vaccine group reported severe diarrhea, compared with 12 in the placebo group.
"These results suggest that the Iomai patch has the potential to fundamentally change the way we approach prevention of this disease, an ailment against which we now have very few weapons," said Herbert L. DuPont, M.D., professor and director of the Center for Infectious Diseases at The University of Texas School of Public Health and the principal investigator of the trial. "If these results are replicated, the Iomai vaccine will have the potential to not only mitigate a disease that sickens millions each year but also keep some patients from going on to develop the chronic symptoms of irritable bowel syndrome."
The Trek Study was done in collaboration with UT Houston, the Johns Hopkins Bloomberg School of Public Health and other institutions. Each volunteer received either two doses of the vaccine patch or a placebo, 2 to 3 weeks apart, with the last dose administered a week before travel. Travelers kept detailed diaries and received in-country checkups. The study was designed to evaluate the safety of the vaccine and the incidence of enterotoxigenic E. coli (ETEC) bacteria - the most common cause of travelers' diarrhea. No vaccine-related serious side effects were reported.
Of the few vaccinated patients who became sick, the diarrhea lasted only half a day on average, while those in the placebo group endured two days of illness and more than twice as many loose stools. Although not statistically significant, the frequency of new-onset irritable bowel syndrome, a long-term consequence of travelers' diarrhea, was three times greater in placebo than vaccine recipients.
This year, approximately 55 million international travelers will visit countries where bacteria that cause travelers' diarrhea are endemic, particularly Africa, Asia and Latin America, and about 20 million of those will develop travelers' diarrhea.
In addition to the acute symptoms of travelers' diarrhea, which include severe diarrhea, abdominal cramps and dehydration, patients who suffer a bout of travelers' diarrhea are also at higher risk of developing irritable bowel syndrome, a chronic condition characterized by pain, bloating, diarrhea or constipation. Diarrheal disease also exacts a significant toll on children in the developing world, where diarrhea linked to enterotoxigenic E. sickens 210 million children each year, killing an estimated 380,000 annually.
"Bacterial diarrheal disease is a significant medical problem both for children and travelers, and our technology represents both an advance in vaccine delivery and a breakthrough in the field of infectious disease," said Gregory Glenn, M.D., Iomai's chief scientific officer. "We look forward to targeting both the significant travelers' market and developing the vaccine for the children in the developing world who still suffer serious morbidity and mortality from this disease."
Iomai plans to initiate a Phase 3 program for the needle-free vaccine patch vaccine in 2009. If approved, the Iomai vaccine would be the first vaccine for travelers' diarrhea available in the United States.
University of Texas Health Science Center at Houston
The Trek Study was done in collaboration with UT Houston, the Johns Hopkins Bloomberg School of Public Health and other institutions. Each volunteer received either two doses of the vaccine patch or a placebo, 2 to 3 weeks apart, with the last dose administered a week before travel. Travelers kept detailed diaries and received in-country checkups. The study was designed to evaluate the safety of the vaccine and the incidence of enterotoxigenic E. coli (ETEC) bacteria - the most common cause of travelers' diarrhea. No vaccine-related serious side effects were reported.
Of the few vaccinated patients who became sick, the diarrhea lasted only half a day on average, while those in the placebo group endured two days of illness and more than twice as many loose stools. Although not statistically significant, the frequency of new-onset irritable bowel syndrome, a long-term consequence of travelers' diarrhea, was three times greater in placebo than vaccine recipients.
This year, approximately 55 million international travelers will visit countries where bacteria that cause travelers' diarrhea are endemic, particularly Africa, Asia and Latin America, and about 20 million of those will develop travelers' diarrhea.
In addition to the acute symptoms of travelers' diarrhea, which include severe diarrhea, abdominal cramps and dehydration, patients who suffer a bout of travelers' diarrhea are also at higher risk of developing irritable bowel syndrome, a chronic condition characterized by pain, bloating, diarrhea or constipation. Diarrheal disease also exacts a significant toll on children in the developing world, where diarrhea linked to enterotoxigenic E. sickens 210 million children each year, killing an estimated 380,000 annually.
"Bacterial diarrheal disease is a significant medical problem both for children and travelers, and our technology represents both an advance in vaccine delivery and a breakthrough in the field of infectious disease," said Gregory Glenn, M.D., Iomai's chief scientific officer. "We look forward to targeting both the significant travelers' market and developing the vaccine for the children in the developing world who still suffer serious morbidity and mortality from this disease."
Iomai plans to initiate a Phase 3 program for the needle-free vaccine patch vaccine in 2009. If approved, the Iomai vaccine would be the first vaccine for travelers' diarrhea available in the United States.
University of Texas Health Science Center at Houston
Diarrhea Current Events and Diarrhea News RSSAsthma a significant risk factor for complications in children with H1N1
A new study on pediatric H1N1 influenza admissions has found that asthma is a significant risk factor for severe disease in children with pandemic H1N1 compared with the seasonal flu.
Prioritizing low-cost, simple health measures would save 2.5 million child lives a year
Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes.
Commentary warns of unexpected consequences of proton pump inhibitor use in reflux disease
Despite being highly effective and beneficial for many patients, unexpected consequences are emerging in patients who are prescribed proton pump inhibitors (PPIs) for reflux diseases.
Deadly stomach infection rising in community settings, Mayo Clinic study finds
Mayo Clinic researchers have found that a sometimes deadly stomach bug, Clostridium difficile is on the rise in outpatient settings.
Probiotic Found to Be Effective Treatment for Colitis In Mice
The probiotic, Bacillus polyfermenticus, can help mice recover from colitis, a new study has found.
Eating right, not supplements, is best at keeping your good bacteria healthy, dietitian says
Healthy eating, not supplements, is the best way to keep the good bacteria in your gut healthy, says a dietitian and researcher.
The bowels of infection
Current research suggests that latent cytomegalovirus (CMV) infection may exacerbate inflammatory bowel disease (IBD). The related report by Onyeagocha et al, "Latent cytomegalovirus infection exacerbates experimental colitis," appears in the November 2009 issue of The American Journal of Pathology.
3-day course of antibiotics may be sufficient following tonsillectomy
Children who receive a three-day course of antibiotics following tonsillectomy rather than a seven-day course appear to have no differences in pain or how quickly they return to a normal diet and activity level.
Countries slow to use lifesaving diarrhea treatments for children
Despite evidence that low-cost diarrhea treatments such as lower osmolarity oral rehydration salts (ORS) and zinc supplements could drastically reduce the number of deaths among children, little progress has been made in implementing these life-saving techniques.
Frozen assets: NIAID researchers turn to unique resource for clues to norovirus evolution
A search through decades-old frozen infant stool samples has yielded rich dividends for scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
More Diarrhea Current Events and Diarrhea News Articles
 |
Kirkland Signiture Anti-Diarrheal - 400 Caplets by Kirkland Controls the symptoms of diarrhea, including Travelers' Diarrhea. Every Kirkland Signature product is guaranteed to meet or exceed the quality standards of the leading national brands. If you are not completely satisfied, your money will be refunded. Directions: Drink plenty of clear fluids to help prevent dehydration, which may accompany diarrhea. Find right dose on chart. If possible, use weight to dose; otherwise, use age. Adults and children 12 years and over: 2 caplets after the first loose stool; 1 caplet after each subsequent loose stool; but no more than 4 caplets a day. Children 9-11 years (60-95 lbs.): 1 caplet after the first loose stool; 1/2 caplet after each subsequent loose stool; but no more than 3caplets a day. Children 6-8 years (48-59 lbs.): 1 caplet after the first... |
 |
Diarrhea (Telford Press Series) by Michael Gracey (Editor) This book helps bring the busy practitioner up to date with recent developments in research on diarrhea that has taken place over the past 10 years. The causes of diarrhea are very diverse and include infections, allergies, chronic inflammatory diseases, tumors and inborn errors of intestinal digestion and transport. The global importance of diarrheal deaths and illnessess, as well as the rapid technical advances that have occurred in this field, have generated a vast amount of literature that is not easily accessible to most practicing doctors. This single volume brings this literature together in a logical, concise and clear manner that puts diarrhea and its management into a clinical perspective. Practicing physicians, pediatricians, internists and senior students will find this book... |
 |
Imodium A-D Anti-Diarrhea, 72-Count Caplets by Imodium Take control with Imodium A-D Anti-Diarrhea Caplets. Imodium works with your body to get it back to normal when you have diarrhea. |
 |
Ask Me About My Explosive Diarrhea Funny Womens Babydoll tee Shirt in 6 Colors Small thru XL by 99 Volts |
 |
Diarrhea by Brandy Lynn McDevitt (Author) Diarrhea. When you see this word on a book's cover, your view of the book may be a little distorted. When you open this book and read, you will learn about Brandy through the ups and downs of her life. Then you will see that the human mind can conquer anything. Brandy grew up without a mother. She had a father who worked nonstop to give her everything she desired. She has matured into a happy, well-rounded, artistic and gifted human...or so it seems. Emotional roller coaster rides in her heart have turned Brandy's mind grey and black with hatred. But she still has light in her soul...a source of energy that she holds...energy that is very beneficial for her. |
 |
NaturVet Cat Anti-Diarrhea Aid 8 fl. oz. by NaturVet 8 oz. NaturVet Cat Anti-Diarrhea Aid is a pleasant tasting liquid suspension for use as an aid for simple diarrhea. Main ingredient is an anti-diarrheal ingredient for the absorption of toxins. This absorbent action helps alleviate the irritation, discomfort and cramping associated with diarrhea. NaturVet Cat Anti-Diarrhea AidNaturVet Cat Anti-Diarrhea Aid is a pleasant tasting liquid suspension for use as an aid for simple diarrhea. NaturVet Cat Anti-Diarrhea contains kaolin, an anti-diarrheal ingredient for the absorption of toxins. This absorbent action helps alleviate the irritation, discomfort and cramping associated with diarrhea. cat diarrhea supplement cat |
 |
Live Fast Diarrhea by The Vandals As evidenced by the title, the Vandals haven't grown up at all on their 5th album, Live Fast Diarrhea. Neither their humor nor their musical skills have developed past the junior high level, as they still pound out three-chord punk at a fast clip, shouting out vulgarities. Features the tracks 'Let The Bad Times Roll', 'And Now We Dance' and more. A Nitro Records. |
 |
Washington Homeopathic Products Combination Remedy for Diarrhea (#10) by Washington Homeopathic Products About Washington Homeopathics (WHP) Washington Homeopathic Pharmacy (WHP) is the world leader in homeopathic and began in 1873 in Washington, DC. In 1991, Joe and Linda Lillard bought the pharmacy. In less than 20 years Washington Homeopathic Products has grown from a storefront pharmacy to one that is now serving over 65,000 customers in more than twenty countries. Today, WHP is the oldest full line homeopathic manufacturer in the nation offering a selection of over 1700 homeopathic medicines. They strive to make just about every product they offer. All plant materials used to manufacture homeopathic medicine must be organically grown. Over 50 species of plants used to process remedies are grown on the Lillards West Virginia farm. Sourcing local botanical materials... |
 |
Constipation and Diarrhea Also With: Guangzhou Beauty Culture Communication Co.Ltd (Producer) Constipation means people relieve nature once for three to five days or even more than five days due to the fact that stool is dry and rough, dejecta stays in the bowels for more than 48 hours. This kind of chronic constipation becomes a very important factor for causing miocardial infarction and cerebral hemorrhage. At present the incidence of a disease of colon cancer has ranked the third cancer. Diarrhea is a phenomena of dysfunction of stomach and bowel.The techniques of treating constipation and hiarrhea by massage of TCM are simple and have actual effects. The speciality theory of this program is clear, and it is paying attention to actual manipulations. It has vivid introductions to the common points, basic techniques and prevention and health care of constipation and diarrhea... |
 |
Diarrhea Betty Blowtorch (Primary Contributor) |
| © 2009 BrightSurf.com |